Latest News for: solu

Edit

Arm­ing SMEs against cy­ber­crime: fo­cus on NIS 2 com­pli­ant solu­tions (Universität Paderborn)

Public Technologies 12 Dec 2024
). The new EU Directive on Network and Information Security (NIS-2 Directive) significantly tightens the IT security requirements for small and medium-sized enterprises (SMEs) ... Implementing NIS 2 requirements efficiently ... small learning activities ... Dr.
Edit

Solu Therapeutics Presents Positive Preclinical Data on STX-0712 for Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting

PR Newswire 09 Dec 2024
"The encouraging results from our preclinical studies in CMML and AML highlight the unique power of our CyTAC platform to precisely target and eliminate disease-driving cells," said Sergio Santillana, Chief Medical Officer of Solu.
Edit

Solu Therapeutics to Present First Preclinical Data of STX-0712 for the Treatment of Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting

PR Newswire 02 Dec 2024
2, 2024 /PRNewswire/ -- Solu Therapeutics ("Solu Therapeutics" or "Solu"), a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, immunology, and other ...
Edit

Hidroxicloroquina � a solu��o? | Vis�o Libert�ria - 30/03/20 | ANCAPSU

Bitchute 25 Oct 2024
Go to the source via the article link to view the video or lcik the video icon ....

Most Viewed

×